DalsnaFinance

Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $49.87, Implies 43% Upside

Stocks TradingView By TradingView 04 Jul 2026 04:20 1 min read
Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $49.87, Implies 43% Upside

Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $49.87, Implies 43% Upside  TradingView

Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $49.87, Implies 43% Upside TradingView

Read the full story on TradingView → Opens the original article on news.google.com

Summary aggregated from TradingView's public RSS feed. The full reporting belongs to TradingView — please read it on their site.